谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: 5-year data from the select-compare study

R. M. Fleischmann,J. Swierkot, S. Penn,P. Durez,L. Bessette,X. Bu, N. Khan, Y. Li,C. Peterfy, Y. Tanaka,E. Mysler

ANNALS OF THE RHEUMATIC DISEASES（2023）

引用 0|浏览15
暂无评分
关键词
Safety,Rheumatoid arthritis,Targeted synthetic drugs
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要